Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Open in API
Filings indexed 680 across all filing types
Latest filing 2019-03-13 Regulatory Filings
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings
2019-03-13 English
Updates
Regulatory Filings Classification · 90% confidence The document is a biographical and professional profile of Nikhil Vora, detailing his career achievements, recognitions, and venture investments. There is no indication of any financial report, regulatory filing, announcement, or presentation related to corporate filings. The content does not match any of the specific filing categories such as Annual Report, Earnings Release, or Investor Presentation. It is purely informational about an individual and his professional background, which does not fit into the defined filing categories. Therefore, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2019-03-02 English
Updates
Interim / Quarterly Report Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) submitting copies of published unaudited consolidated financial results for the quarter and nine months ended December 31, 2018. It includes detailed financial data such as total income, net profit/loss, earnings per share, and other financial metrics for the quarter and nine months. The document references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs quarterly financial results disclosures. The presence of actual financial data and the focus on quarterly and nine-month periods indicate this is a comprehensive interim financial report rather than just an announcement or summary. The document is not a full annual report (10-K), nor is it a brief earnings release (ER) since it contains detailed financial tables. It is not a certification or attestation letter, so it is not Regulatory Filings (RNS). Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2019
2019-02-13 English
Press Release
Regulatory Filings
2019-02-12 English
Financial Result Updates
Regulatory Filings
2019-02-12 English
Outcome of Board Meeting
Regulatory Filings
2019-02-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.